India Agencies Draft Nation's First Guidelines For Biosimilars
This article was originally published in PharmAsia News
Executive Summary
India's Department of Biotechnology and its Central Drugs Standard Control Organization have completed a final draft of guidelines covering biosimilars, and includes preclinical testing to post-marketing studies.